Clinical Trials Browser

INDUSTRY × Dasatinib × Thoracic × Clear all

NCT01514864 2023-12-19

Trial of Dasatinib in Patients With Advanced Cancers Harboring DDR2 Mutation or Inactivating B-RAF Mutation

Phase 2 Terminated

19 enrolled 18 charts

Carcinoma, Non-Small-Cell Lung